News

Filter

Current filters:

Astellas PharmaVaprisol

Vaprisol raises sodium levels in hyponatremia

05-11-2007

Japanese-owned Astellas Pharma US says that new clinical data indicates that its drug Vaprisol (conivaptan…

Amino AcidsAstellas PharmaConivaptan Hcl InjectionInjectionPhysostigmine SalicylatePitressinVaprisolVasopressin

New Vaprisol indication ushers in age of aquaresis

12-03-2007

Astellas Pharma US, a subsidiary of Japan's Astellas, says that the Food and Drug Administration has…

Amino AcidsAstellas PharmaConivaptan Hcl InjectionInjectionPhysostigmine SalicylateVaprisol

FDA clears Astellas' Vaprisol for hypervolemic hyponatremia

12-03-2007

The US subsidiary of Japan's Astellas Pharma has received Food and Drug Administration approval for its…

Amino AcidsAstellas PharmaConivaptan Hcl InjectionInjectionPhysostigmine SalicylatePitressinVaprisolVasopressin

Astellas to conduct multicenter Asian trial of Factor Xa inhibitor - YM150

27-11-2006

Japan's Astellas Pharma, the country's second largest drugmaker by sales, has announced that it will…

Astellas PharmaCelebrexcelecoxibConivaptan Hcl InjectionPitressinPrografProtopictacrolimusVaprisolVasopressin

Astellas Pharma's Vaprisol gains FDA approval

09-01-2006

The US subsidiary of Japan's Astellas Pharma says that its drug Vaprisol (conivaptan hydrochloride injection)…

Amino AcidsAstellas PharmaConivaptan Hcl InjectionInjectionPhysostigmine SalicylateVaprisol

Back to top